UC launches gene therapy trial to transform the treatment of sickle cell disease
        
            By Lisa M. Krieger, 
                The Mercury News
             | 03. 31. 2021
        
            CRISPR gene editing corrects the defect that causes blood disease
                    
                                    
                    
                                                                                                                                    
                                                                            
                              
    
  
  
    
  
          
  
      
    
            "Sickle cell disease (SCD)" by National Institutes
of Health (NIH) is licensed under CC BY-NC 2.0
A team of University of California scientists are launching a first-ever human study of a powerful new gene-editing technique to fix the bad gene that causes sickle cell disease, offering the promise of a cure for the devastating blood illness.
On Tuesday, researchers announced that they have received U.S. Food and Drug Administration approval to test the approach, using a technique called CRISPR-Cas9, at UCSF Benioff Children’s Hospital Oakland and UCLA’s Broad Stem Cell Research Center.
“Our goal is to be able to deliver a safe and effective therapy that we can administer as soon as we know the diagnosis — and spare those children and young adults all the complications of this disorder.” said Dr. Mark Walters, a professor of pediatrics at UCSF and principal investigator of the project.
For 65 years, scientists have known the cause of sickle cell disease but have been unable to cure it without a bone marrow transplant. By fixing the underlying genetic problem, the new research buoys...
 
       
 
  
 
    
    
  
   
                        
                                                                                
                 
                                                    
                            
                                  
    
  
  
      Related Articles
    
  
          
  
  
  
  
  
  
      
            
                  
  
      
    
    
    
    
            Paula Amato & Shoukhrat Mitalipov
[OHSU News/Christine Torres Hicks]
On September 30th, a team of 21 scientists from Oregon Health & Science University (OHSU) published a significant paper in Nature Communications, with a scientifically accurate but, to many, somewhat abstruse headline:
Induction of experimental cell division to generate cells with reduced chromosome ploidy
The lead authors were Shoukhrat Mitalipov, recently described here as “a push-the-envelope biologist,” and his long-term colleague Paula Amato. (Recall that in July the pair had co-published with...
 
       
 
 
  
      
    
    
                
                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                           By Pam Belluck,  The New York Times | 10.17.2025
                                                        
     
    
    
            Before dawn on a March morning, Doug Whitney walked into a medical center 2,000 miles from home, about to transform from a mild-mannered, bespectacled retiree into a superhuman research subject.
First, a doctor inserted a needle into his back to...
 
       
 
 
  
      
    
    
                
                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                           By Elizabeth Dwoskin and Zoeann Murphy,  The Washington Post | 10.01.2025
                                                        
     
    
    
            MEXICO CITY — When she walked into an IVF clinic in June, Alin Quintana knew it would be the last time she would try to conceive a child. She had prepared herself spiritually and mentally for the visit: She had traveled to a nearby...
 
       
 
 
  
      
    
    
                
                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                           By Rob Stein,  NPR | 09.30.2025
                                                        
     
    
    
            Scientists have created human eggs containing genes from adult skin cells, a step that someday could help women who are infertile or gay couples have babies with their own genes but would also raise difficult ethical, social and legal issues...